The Role of Corticotropin-Releasing Factor (CRF) in Preclinical Models of Depression

키워드

참고문헌 (102)

1. Swanson LW, "Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study", Neuroendocrinology, 36, pp.165~186 (1983)
2. Yan XX, "Colocalization of corticotropin-releasing hormone with glutamate decarboxylase and calcium-binding proteins in infant rat neocortical interneurons", Exp Brain Res, 123, pp.334~340 (1998)
3. Gutknecht E, "Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling", Mol Pharmacol, 75, pp.648~657 (2009)
4. Grigoriadis DE, "125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors", Mol Pharmacol, 50, pp.679~686 (1996)
5. Chalmers DT, "Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression", J Neurosci, 15, pp.6340~6350 (1995)
6. Herman JP, "Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis", Trends Neurosci, 20, pp.78~84 (1997)
7. Ulrich-Lai YM, "Neural regulation of endocrine and autonomic stress responses", Nat Rev Neurosci, 10, pp.397~409 (2009)
8. Hammack SE, "Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress", J Mol Neurosci (2010)
9. de Olmos JS, "The concepts of the ventral striatopallidal system and extended amygdala", Ann N Y Acad Sci, 877, pp.1~32 (1999)
10. Dong HW, "Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain", J Comp Neurol, 436, pp.430~455 (2001)
11. Cassell MD, "The intrinsic organization of the central extended amygdala", Ann N Y Acad Sci, 877, pp.217~241 (1999)
12. Davis M, "Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety", Neuropsychopharmacology, 35, pp.105~135 (2010)
13. Erb S, "A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stressinduced reinstatement of cocaine seeking in rats", Psychopharmacology (Berl), 158, pp.360~365 (2001)
14. Jasnow AM, "Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin- releasing factor in behavioral responses to social defeat", Behav Neurosci, 118, pp.1052~1061 (2004)
15. Davis M, "The role of the amygdala in fear and anxiety", Ann Rev Neurosci, 15, pp.353~375 (1992)
16. Lee Y, "Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex", J Neurosci, 17, pp.6434~6446 (1997)
17. Walker DL, "Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer", Brain Struct Funct, 213, pp.29~42 (2008)
18. Walker D, "Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses", Neuropsychopharmacology, 34, pp.1533~1542 (2009)
19. Walker DL, "Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.1291~1308 (2009)
20. Stout SC, "Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats", Eur J Pharmacol, 401, pp.39~46 (2000)
21. Kim SJ, "Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats", Neuropharmacology, 50, pp.824~833 (2006)
22. Ciccocioppo R, "The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin", orphanin FQ, 2003, pp.23, 9445~9451
23. Regev L, "Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation", Mol Psychiatry (2010)
24. Valentino RJ, "Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region", Neuroscience, 106, pp.375~384 (2001)
25. Lee HS, "Glutamatergic afferent projections to the dorsal raphe nucleus of the rat", Brain Res, 963, pp.57~71 (2003)
26. Valentino RJ, "Corticotropin- releasing factor in the dorsal raphe nucleus: linking stress coping and addiction", Brain Res, 1314, pp.29~37 (2010)
27. Maier SF, "Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor", Neurosci Biobehav Rev, 29, pp.829~841 (2005)
28. Kirby LG, "Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons", J Neurosci, 28, pp.12927~12937 (2008)
29. Van Bockstaele EJ, "Corticotropinreleasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain", J Comp Neurol, 364, pp.523~534 (1996)
30. Curtis AL, "Corticotropin- releasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress", J Neuroendocrinol, 14, pp.667~682 (2002)
31. Van Pett K, "Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse", J Comp Neurol, 428, pp.191~212 (2000)
32. Kreibich A, "Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system", J Neurosci, 28, pp.6516~6525 (2008)
33. Jedema HP, "Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro", J Neurosci, 24, pp.9703~9713 (2004)
34. Aston-Jones G, "An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance", Annu Rev Neurosci, 28, pp.403~450 (2005)
35. Berridge CW, "The locus coeruleus-noradrenergic system: Modulation of behavioral state and statedependent cognitive processes", Brain Res Brain Res Rev, 42, pp.33~84 (2003)
36. Valentino RJ, "Convergent regulation of locus coeruleus activity as an adaptive response to stress", Eur J Pharmacol, 583, pp.194~203 (2008)
37. Price ML, "Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor", J Neurosci, 21, pp.2833~2841 (2001)
38. Price ML, "Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming", Psychopharmacology (Berl), 162, pp.406~414 (2002)
39. Waselus M, "Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system", J Comp Neurol, 482, pp.155~165 (2005)
40. Roche M, "Circuitry underlying regulation of the serotonergic system by swim stress", J Neurosci, 23, pp.970~977 (2003)
41. Waselus M, "Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus", Biol Psychiatry, 66, pp.76~83 (2009)
42. Curtis AL, "Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus", Neuroscience, 65, pp.541~550 (1995)
43. Curtis AL, "Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress", J Pharmacol Exp Ther, 289, pp.1211~1219 (1999)
44. Heim C, "The link between childhood trauma and depression: insights from HPA axis studies in humans", Psychoneuroendocrinology, 33, pp.693~710 (2008)
45. Heim C, "Importance of studying the contributions of early adverse experience to neurobiological findings in depression", Neuropsychopharmacology, 29, pp.641~648 (2004)
46. Jans JE, "Nest temperature: effects on maternal behavior, pup development, and interactions with handling", Dev Psychobiol, 23, pp.519~534 (1990)
47. Plotsky PM, "Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring", Neuropsychopharmacology, 30, pp.2192~2204 (2005)
48. Forbes NF, "Chronic mild stress and sucrose consumption: validity as a model of depression", Physiol Behav, 60, pp.1481~1484 (1996)
49. Willner P, "Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation", Psychopharmacology (Berl), 134, pp.319~329 (1997)
50. Nestler EJ, "Neurobiology of depression", Neuron, 34, pp.13~25 (2002)
51. Grahn RE, "Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor", Brain Res, 826, pp.35~43 (1999)
52. Amat J, "Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat", Brain Res, 812, pp.113~120 (1998)
53. Bland ST, "Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex", Neuropsychopharmacology, 28, pp.1589~1596 (2003)
54. Hammack SE, "The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress", J Neurosci, 22, pp.1020~1026 (2002)
55. Hammack SE, "Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress", J Neurosci, 23, pp.1019~1025 (2003)
56. van der Linden GJ, "The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials", Int Clin Psychopharmacol, 15(2), pp.15~23 (2000)
57. Maier SF, "Chlordiazepoxide microinjected into the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing", Behav Neurosci, 108, pp.121~130 (1994)
58. Kessler RC, "Impairment in p and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys", Am J Psychiatry, 156, pp.1915~1923 (1999)
59. Overstreet DH, "The Flinders Sensitive Line rat: a selectively bred putative animal model of depression", Neurosci Biobehav Rev, 29, pp.739~759 (2005)
60. Janowsky DS, "Is cholinergic sensitivity a genetic marker for the affective disorders?", Am J Med Genet, 54, pp.335~344 (1994)
61. Pucilowski O, "Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression", Physiol Behav, 54, pp.1215~1220 (1993)
62. Zambello E, "Acute stress differentially affects corticotropinreleasing hormone mRNA expression in the central amygdala of the "depressed" flinders sensitive line and the control flinders resistant line rats", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.651~661 (2008)
63. Owens MJ, "Alterations in the hypothalamic- pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity", Neuropsychopharmacology, 4, pp.87~93 (1991)
64. van Gaalen MM, "Effects of transgenic overproduction of CRH on anxietylike behaviour", Eur J Neurosci, 15, pp.2007~2015 (2002)
65. Heinrichs SC, "Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated", Psychoneuroendocrinology, 22, pp.215~224 (1997)
66. Kimura M, "Conditional corticotropinreleasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep", Mol Psychiatry, 15, pp.154~165 (2010)
67. Wiersma A, "Differential effects of CRH infusion into the central nucleus of the amygdala in the Roman high-avoidance and low-avoidance rats", Psychoneuroendocrinology, 23, pp.261~274 (1998)
68. Quattrochi J, "Cholinergic and noncholinergic afferents of the caudolateral parabrachial nucleus: a role in the long-term enhancement of rapid eye movement sleep", Neuroscience, 83, pp.1123~1136 (1998)
69. Dunn AJ, "Behavioral responses to stress are intact in CRF-deficient mice", Brain Res, 845, pp.14~20 (1999)
70. Weninger SC, "Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency", Endocrinology, 141, pp.256~263 (2000)
71. Keck ME, "Listening to mutant mice: a spotlight on the role of CRF", CRF receptor systems in affective disorders, 2005, pp.29, 867~889
72. Koob GF, "Corticotropin releasing factor, stress and behavior", Semin Neurosci, 6, pp.221~229 (1994)
73. Dunn AJ, "Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?", Brain Res Brain Res Rev, 15, pp.71~100 (1990)
74. Britton DR, "Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty", Life Sci, 31, pp.363~367 (1982)
75. Sutton RE, "Corticotropin releasing factor produces behavioural activation in rats", Nature, 297, pp.331~333 (1982)
76. Berridge CW, "A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice", Horm Behav, 21, pp.393~401 (1987)
77. Takahashi LK, "Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats", Behav Neurosci, 103, pp.648~654 (1989)
78. Sherman JE, "ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity", Pharmacol Biochem Behav, 30, pp.801~807 (1988)
79. Sirinathsinghji DJ, "Corticotropin- releasing factor is a potent inhibitor of sexual receptivity in the female rat", Nature, 305, pp.232~235 (1983)
80. Swerdlow NR, "Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide", Psychopharmacology (Berl), 88, pp.147~152 (1986)
81. Liang KC, "Campeau S, Davis M. Corticotropin-releasing factor: longlasting facilitation of the acoustic startle reflex", J Neurosci, 12, pp.2303~2312 (1992)
82. Krahn DD, "CRF antagonist partially reverses CRF- and stress-induced effects on feeding", Brain Res Bull, 17, pp.285~289 (1986)
83. Arase K, "Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats", Am J Physiol, 255, pp.255~259 (1988)
84. Cador M, "Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role", Brain Res, 597, pp.304~309 (1992)
85. Heinrichs SC, "Endogenous corticotropin- releasing factor modulates feeding induced by neuropeptide Y or a tailpinch stressor", Peptides, 13, pp.879~884 (1992)
86. File SE, "The contribution of behavioural studies to the neuropharmacology of anxiety", Neuropharmacology, 26, pp.877~886 (1987)
87. Banki CM, "CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia", Am J Psychiatry, 144, pp.873~877 (1987)
88. Aratóo M, "Elevated CSF CRF in suicide victims", Biol Psychiatry, 25, pp.355~359 (1989)
89. Wong ML, "Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropinreleasing hormone", Proc Nat Acad USA, 97, pp.325~330 (2000)
90. Heuser I, "Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment", Depress Anxiety, 8, pp.71~79 (1998)
91. Kasckow JW, "Corticotropinreleasing hormone in depression and post-traumatic stress disorder", Peptides, 22, pp.845~851 (2001)
92. Gold PW, "Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH", NE states, 2002, pp.7, 254~275
93. Nikisch G, "CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy", Eur Psychiatry, 23, pp.356~359 (2008)
94. Bissette G, "Elevated concentrations of CRF in the locus coeruleus of depressed subjects", Neuropsychopharmacology, 28, pp.1328~1335 (2003)
95. Kling MA, "Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings", Psychopharmacol Bull, 30, pp.489~494 (1994)
96. Nikisch G, "Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response", J Clin Psychopharmacol, 24, pp.283~290 (2004)
97. Nikisch G, "Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram", Int J Neuropsychopharmacol, 8, pp.403~410 (2005)
98. De Bellis MD, "Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression", Am J Psychiatry, 150, pp.656~657 (1993)
99. Zorrilla EP, "Progress in corticotropin-releasing factor-1 antagonist development", Drug Discov Today, 15, pp.371~383 (2010)
100. Nielsen DM, "Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice", Eur J Pharmacol, 499, pp.135~146 (2004)
101. Jutkiewicz EM, "The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats", Psychopharmacology (Berl), 180, pp.215~223 (2005)
102. Chaki S, "Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995", CRA0450, 2004, pp.485, 145~158

관련 논문AI추천